Artigos de revistas sobre o tema "PT Indofarma"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "PT Indofarma".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Paramesti, Aswini, and Yugih Setyanto. "Strategi Komunikasi PT Indofarma Tbk dalam Membangun Kepercayaan Konsumen di Masa Pandemi." Kiwari 1, no. 1 (2022): 62. http://dx.doi.org/10.24912/ki.v1i1.15508.
Texto completo da fonteWahida Basri, Nur, Muh Rum, and Andi Rustam. "Comparison of Financial Performance in Pharmaceutical Industry Companies." Golden Ratio of Finance Management 4, no. 2 (2024): 226–41. http://dx.doi.org/10.52970/grfm.v4i2.459.
Texto completo da fonteSulistyani, Tri, and Neneng Tita Amalya. "Analysis of Financial Performance in Pharmaceutical Industry Sub-Sector Companies in Indonesia for the 2020 – 2022 Period." Transforma Jurnal Manajemen 2, no. 2 (2024): 52–64. http://dx.doi.org/10.56457/tjm.v2i2.128.
Texto completo da fontePrihatiningrum, Nadia, and Lalu Husni. "Implementasi Penerapan Upah Minimum Kota Mataram Terhadap Pekerja Pada PT. Indofarma Global Medika." Private Law 4, no. 1 (2024): 139–49. https://doi.org/10.29303/prlw.v4i1.3928.
Texto completo da fonteAtiyah Kirana Ropidah and Diana Wiyanti. "Implementasi GCG PT. Indofarma Terkait Kasus Fraud Berdasarkan Permen BUMN No. Per-2/MBU/2023." Bandung Conference Series: Law Studies 5, no. 1 (2025): 233–42. https://doi.org/10.29313/bcsls.v5i1.15996.
Texto completo da fonteKurniati, Eling Ri, and Tryan Adhi Nugroho. "ANALISIS KINERJA KEUANGAN PT. KIMIA FARMA TBK DENGAN PT. INDOFARMA TBK SEBELUM PANDEMI DAN PADA SAAT PANDEMI COVID-19." Medikonis 13, no. 1 (2022): 20–28. http://dx.doi.org/10.52659/medikonis.v13i1.48.
Texto completo da fonteAviariska Primaning Happy. "Kepastian Hukum Dari Akta Keputusan Hasil e-RUPS Studi Kasus pada PT. Indofarma Tbk Tahun Buku 2019." Jurnal Akta Notaris 3, no. 2 (2024): 148–59. https://doi.org/10.56444/aktanotaris.v3i2.2154.
Texto completo da fonteDeni, Muhammad. "Pengaruh Etos Kerja Terhadap Kinerja Karyawan PT Indofarma Global Medika Cabang Palembang." Jurnal Manajemen Kompeten 4, no. 2 (2022): 56. http://dx.doi.org/10.51877/mnjm.v4i2.207.
Texto completo da fonteAwalya, Nabila, Yusnizal Firdaus, and Marieska Lupikawaty. "Analisis Rasio Profitabilitas Untuk Menilai Kinerja Keuangan pada PT Indofarma Tbk." Jurnal Terapan Ilmu Ekonomi, Manajemen dan Bisnis 2, no. 3 (2022): 127–34. https://doi.org/10.5281/zenodo.7473285.
Texto completo da fonteHandayani, Lovinta Valentina, and Mohamad Heykal. "Analisis dan Penilaian Bisnis Perusahaan BUMN di Industri Farmasi: Studi Kasus Kimia Farma dan Indofarma Tahun 2006-2008." Binus Business Review 3, no. 1 (2012): 155. http://dx.doi.org/10.21512/bbr.v3i1.1291.
Texto completo da fonteJunaedi, Junaedi. "PENGARUH CURRENT RATIO, DEBT TO EQUITY RATIO DAN TOTAL ASSET TURNOVER TERHADAP RETURN ON ASSET STUDI PADA PT. INDOFARMA Tbk YANG TERDAFTAR DI BURSA EFEK INDONESIA PERIODE 2015-2019." EKONOMI BISNIS 26, no. 2 (2020): 358–66. http://dx.doi.org/10.33592/jeb.v26i2.1045.
Texto completo da fonteWidyastuti, Indriyana, and Saptani Rahayu. "Akurasi Potensi Memprediksi Kebangkrutan Metode Altman Z-Score Dan Metode Ohlson O-Score." ProBank 3, no. 2 (2018): 1–7. http://dx.doi.org/10.36587/probank.v3i2.369.
Texto completo da fonteWidyastuti, Indriyana, and Saptani Rahayu. "Akurasi Potensi Memprediksi Kebangkrutan Metode Altman Z-Score Dan Metode Ohlson O-Score." ProBank 3, no. 2 (2018): 1–7. http://dx.doi.org/10.36587/probank.v3i2.369.
Texto completo da fonteMuna Jihan, Lintang Woro, and Risma Ajeng. "Analisis Selisih Nilai Tukar dan Transaksi Mata Uang Asing Pada PT Indofarma Tbk dan Entitas Anak." Jurnal Kendali Akuntansi 2, no. 1 (2023): 189–200. https://doi.org/10.59581/jka-widyakarya.v2i1.2045.
Texto completo da fonteNuha, Muhammad Ulin. "Analisis Kinerja Perusahaan Berbasis Balance Scorecard." Jurnal Akuntansi, Manajemen dan Perbankan Syariah 2, no. 3 (2022): 1–13. https://doi.org/10.32699/jamasy.v2i3.2822.
Texto completo da fonteHamida, Wulan, Ine Mayasari, Banter Laksana, and Dadang Hermawan. "Analysis of Optimal Capital Structure in the Pharmaceutical Industry Companies Listed on the Indonesia Stock Exchange." Indonesian Journal of Economics and Management 3, no. 1 (2022): 61–69. http://dx.doi.org/10.35313/ijem.v3i1.3117.
Texto completo da fonteAzzahra, Shafira, Sifa Nuraeni, Risna Haryati, Ruli Mochammad Chaerudin, and Tatiek Ekawati Permana. "ANALISIS KINERJA RASIO PROFITABILITAS PADA PERUSAHAAN MANUFAKTUR SEKTOR FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA TAHUN 2019-2022." JURNAL EKONOMI BISNIS DAN MANAJEMEN (EKO-BISMA) 3, no. 2 (2024): 275–84. https://doi.org/10.58268/eb.v3i2.119.
Texto completo da fonteIsmail, Rizky. "Analisis Rasio Keuangan Untuk Menilai Kinerja Keuangan Perusahaan Kimia Farma Tbk dan PT Indofarma Tbk Periode waktu 1 Tahun." J-AKSI : JURNAL AKUNTANSI DAN SISTEM INFORMASI 4, no. 1 (2023): 1–7. http://dx.doi.org/10.31949/jaksi.v4i1.3026.
Texto completo da fontePudjiani, Meilina, Yusman Syaukat, and Tony Irawan. "Optimum Portfolio Analysis of Black-Litterman Model in The Indonesian Stock Exchange on Consumer Goods Industrial Sector." Winners 21, no. 1 (2020): 27. http://dx.doi.org/10.21512/tw.v21i1.5954.
Texto completo da fontePrayoga, Dwiputra Pangestu, Setiawan Temy, and Sugiono Arief. "Fraud Analysis at PT Indofarma Indonesia: A Contextual Qualitative Study using the Fraud Hexagon Model." INTERNATIONAL JOURNAL OF MULTIDISCIPLINARY RESEARCH AND ANALYSIS 08, no. 05 (2025): 2253–58. https://doi.org/10.5281/zenodo.15380382.
Texto completo da fonteGlorya Oktavianti, Bernike Trivena N, and Boniface Ata D. "ANALISA LAPORAN KEUANGAN PERUSAHAAN FARMASI TAHUN 2019-2022." Transformasi: Journal of Economics and Business Management 1, no. 4 (2022): 178–92. http://dx.doi.org/10.56444/transformasi.v1i4.279.
Texto completo da fonteRidianto, Rini, Ravika Permata Hati, and Hanafi Siregar. "Pengaruh Pertumbuhan Perusahaan, Return On Investment Dan Earning Per Share Terhadap Harga Saham Pada Pt. Kimia Farma Dan Pt. Indofarma Sebelum Dan Selama Pandemi Covid-19." Measurement Jurnal Akuntansi 18, no. 1 (2024): 121–30. http://dx.doi.org/10.33373/mja.v18i1.6436.
Texto completo da fonteSaputra, Derian, and Anum Nuryani. "Analisis Financial Distress Menggunakan Metode Altman Z-Score pada PT Indofarma Tbk Periode 2013-2022." AMANAH : Jurnal Ilmiah Ilmu Manajemen 2, no. 2 (2024): 92–108. https://doi.org/10.70451/amanah.v2i2.114.
Texto completo da fonteMokoginta, Rena Mustari. "Mengukur Kinerja Keuangan Menggunakan Eva dan Rasio Aktivitas Pada Industri Farmasi Setelah Holding BUMN." ARBITRASE: Journal of Economics and Accounting 4, no. 1 (2023): 23–32. http://dx.doi.org/10.47065/arbitrase.v4i1.1052.
Texto completo da fonteHangline Herlistiana, Pratista, MGS Aritonang, and Tedy Herdiana. "The Effect of Production and Sales on Leverage and Profitability in The JKN Era (State-Owned and Private Pharmaceutical Companies Tbk, Period 2014–2018)." Daengku: Journal of Humanities and Social Sciences Innovation 3, no. 4 (2023): 662–75. http://dx.doi.org/10.35877/454ri.daengku1921.
Texto completo da fonteLinda, Nur, and Sri Hermuningsih. "ANALISIS KINERJA KEUANGAN SEBELUM DAN SESUDAH PEMBENTUKAN HOLDING BUMN FARMASI PADA PT KIMIA FARMA, Tbk dan PT INDOFARMA, Tbk." CAPITAL: Jurnal Ekonomi dan Manajemen 6, no. 2 (2023): 447. http://dx.doi.org/10.25273/capital.v6i2.14488.
Texto completo da fonteSoviatun, Nuria, and Jerry Heikal. "THE CHANGES IN FINANCIAL PERFORMANCE SEGMENTATION USING FINANCIAL RATIOS PHARMACEUTICAL COMPANIES IN INDONESIA." Cerdika: Jurnal Ilmiah Indonesia 3, no. 08 (2023): 828–39. http://dx.doi.org/10.59141/cerdika.v3i08.688.
Texto completo da fonteDesmaniar, Salwa Anisya, Listri Herlina, and Ilham Winar Nugroho. "Pengaruh Current Ratio, Debt to Asset Ratio, dan Total Asset Turnover Terhadap Return on Asset Pada PT IndoFarma (INAF) Tbk Periode 2014-2023." Jurnal Ilmu Sosial, Manajemen, Akuntansi dan Bisnis 5, no. 3 (2024): 550–61. http://dx.doi.org/10.47747/jismab.v5i3.1941.
Texto completo da fonteManossoh, Hendrik, and Joanne Valesca Mangindaan. "DAMPAK PANDEMI COVID-19 TERHADAP HARGA SAHAM PT. INDOFARMA TBK." JMBI UNSRAT (Jurnal Ilmiah Manajemen Bisnis dan Inovasi Universitas Sam Ratulangi). 10, no. 1 (2023): 539–47. http://dx.doi.org/10.35794/jmbi.v10i1.48182.
Texto completo da fonteNoviarty, Helisa, and Yuniarsih Edryani. "DAMPAK PANDEMI COVID-19 TERHADAP PENGUNGKAPAN TANGGUNG JAWAB SOSIAL PADA SEKTOR FARMASI." JAAKFE UNTAN (Jurnal Audit dan Akuntansi Fakultas Ekonomi Universitas Tanjungpura) 10, no. 2 (2021): 11. http://dx.doi.org/10.26418/jaakfe.v10i2.50961.
Texto completo da fonteRosa, Sara Nurdia, Ledia Tereza, Efa Agustina, Yulana Desilfa, and Dian Puji Puspita Sari. "Formation of Optimal Portfolio Using A Single Index in Pharmaceutical Companies." Research in Accounting Journal (RAJ) 4, no. 1 (2023): 19–26. https://doi.org/10.37385/raj.v3i1.1892.
Texto completo da fonteManungkalit, Santa Maria, Dimas Sumitra Danisworo, and Banter Laksana. "Analisis Rasio Profitabilitas untuk Menilai Kinerja Keuangan PT Indofarma (Persero),Tbk." Indonesian Journal of Economics and Management 2, no. 3 (2022): 621–29. http://dx.doi.org/10.35313/ijem.v2i3.3739.
Texto completo da fonteUtami, Ismi Fauzi, and Wuri Widyani Hapsari. "PENERAPAN IDENTITAS VISUAL PERUSAHAAN PT. BIO FARMA (PERSERO) MELALUI DESAIN GRAFIS PADA MEDIA SOSIAL INSTAGRAM." VISWA DESIGN: Journal of Design 3, no. 2 (2023): 122–33. http://dx.doi.org/10.59997/vide.v3i2.1410.
Texto completo da fonteMulatsih, Dyah Ajeng, and Irni Yunita. "ANALISIS KINERJA DAN KESEHATAN KEUANGAN PERUSAHAAN PADA INDUSTRI FARMASI DENGAN METODE DU PONT SYSTEM DAN MODEL ALTMAN Z-SCORE." Jurnal Mitra Manajemen 3, no. 1 (2019): 44–56. http://dx.doi.org/10.52160/ejmm.v3i1.178.
Texto completo da fonteDevi Savira S and Sri Trisnaningsih. "Violation of Accountant Professional Ethics in the Case of PT. Indofarma Tbk." International Journal of Management Research and Economics 3, no. 1 (2024): 36–45. https://doi.org/10.54066/ijmre-itb.v3i1.2551.
Texto completo da fonteFernawati, Amelia Fernawati, and Dhea Lestari Noor Putri. "Analisis Rasio Profitabilitas dan Rasio Aktivitas Sebagai Dasar Penilaian Kinerja Keuangan Pada PT Indofarma (Persero) Tbk Periode Maret 2014-2018." Jurnal Aktiva : Riset Akuntansi dan Keuangan 2, no. 1 (2022): 35–45. http://dx.doi.org/10.52005/aktiva.v2i1.145.
Texto completo da fonteOctavianty, Ellyn, and Muhamad Syahrial. "ANALISIS FUNDAMENTAL TERHADAP KINERJA KEUANGAN UNTUK PENGAMBILAN KEPUTUSAN PEMBELIAN SAHAM PADA PERUSAHAAN BUMN YANG TERDAFTAR DI BEI." JIMFE (Jurnal Ilmiah Manajemen Fakultas Ekonomi) 6, no. 1 (2018): 17–25. http://dx.doi.org/10.34203/jimfe.v6i1.468.
Texto completo da fonteSofyan Marwansyah, Rani Kurniasari, Teni Agustina, and Nurlaela Eva Puji Lestari. "Analisis Evaluasi Kinerja Portofolio Saham dengan Metode Sharpe pada Perusahaan Farmasi." GEMILANG: Jurnal Manajemen dan Akuntansi 5, no. 2 (2025): 271–82. https://doi.org/10.56910/gemilang.v5i2.1965.
Texto completo da fonteDewi, Iriana Kusuma, and Putri Nilam Kencana. "Dampak Pandemi Covid-19 Terhadap Kinerja Perusahaan Farmasi yang terdaftar di BEI." Jurnal Madani: Ilmu Pengetahuan, Teknologi, dan Humaniora 5, no. 1 (2022): 54–67. http://dx.doi.org/10.33753/madani.v5i1.197.
Texto completo da fonte., Susilawati, O. Feriyanto, and Dessy Nurlaelasari. "Pengaruh Perputaran Persediaan dan Perputaran Total Aset Terhadap Profitabilitas Pada PT Indofarma (Persero) Tbk." STAR 14, no. 1 (2022): 22. http://dx.doi.org/10.55916/jsar.v14i1.33.
Texto completo da fonteMadewi, Astuti. "ANALISIS PREDIKSI KEBANGKRUTAN MENGGUNAKAN MODEL ALTMAN Z-SCORE PT. INDOFARMA TBK TAHUN 2020-2022." ECONOMIST: Jurnal Ekonomi dan Bisnis 1, no. 3 (2024): 12–21. https://doi.org/10.63545/economist.v1i3.26.
Texto completo da fonteWahyuni, Liza, and Charoline Cheisviyanny. "Analisis Praktik Corporate Social Responsibility (CSR) Saat Pandemi Covid-19 pada Perusahaan Farmasi." JURNAL EKSPLORASI AKUNTANSI 5, no. 3 (2023): 1065–83. http://dx.doi.org/10.24036/jea.v5i3.794.
Texto completo da fonteRohmah, Siti, Erni Setawati, Pantas P. Pardede, and Mutiara Rahman. "DETERMINAN DETEKSI KECURANGAN LAPORAN KEUANGAN." Jurnal GeoEkonomi 15, no. 1.2024 (2024): 131–40. http://dx.doi.org/10.36277/geoekonomi.v15i1.2024.440.
Texto completo da fonteRahmawati, Ira, and Dini Verdania Latif. "Pengaruh Total Aset Turnover (Tato) Dan Return On Equity(Roe) Terhadap Pertumbuhan Laba (Studi Kasus Pada Perusahaan Sektor Farmasi Yang Terdaftar Di Bursa Efek Indonesia Selama Masa Pandemi Covid -19)." Journal of Economic, Bussines and Accounting (COSTING) 6, no. 2 (2023): 1886–95. http://dx.doi.org/10.31539/costing.v6i2.5371.
Texto completo da fonteFernawati, Amelia Fernawati. "Analisis Rasio Profitabilitas dan Rasio Keuangan Sebagai Dasar Penilaian Kinerja Keuangan Pada PT. Indofarma (Persero) Tbk Periode Maret 2014-2018." Jurnal Aktiva : Riset Akuntansi dan Keuangan 1, no. 3 (2020): 35–45. http://dx.doi.org/10.52005/aktiva.v2i1.50.
Texto completo da fonteHairani, Yuniar Is, and Isnawati Isnawati. "DETERMINAN POTENSI KECURANGAN LAPORAN KEUANGAN DI INDONESIA." Jurnal Riset Akuntansi Aksioma 23, no. 1 (2024): 1–21. http://dx.doi.org/10.29303/aksioma.v23i1.267.
Texto completo da fonteRambe, Muhammad Juang, Wahyu Indah Sari, and Danioko S. Sembiring. "The position of state-owned enterprises: Towards a health sector super holding company paradigm." Proceeding of International Conference on Healthy Living (INCOHELIV) 1, no. 1 (2024): 315–22. http://dx.doi.org/10.24123/incoheliv.v1i1.6586.
Texto completo da fonteAbdurrahman, Abdurrahman, and Aris Munandar. "ANALISIS RASIO KEUANGAN UNTUK MENILAI KINERJA KEUANGAN PERUSAHAAN FARMASI PT. INDOFARMA, Tbk TAHUN 2011 – 2018." MOTIVASI 5, no. 2 (2020): 860. https://doi.org/10.32502/mti.v5i2.2824.
Texto completo da fonteUriawan, Wisnu, and Iwan Permana. "Effect of Return on Assets (ROA) and Leverage Ratio on Company Value of PT. MNC Land Tbk." Journal of Islamic Economics and Business 2, no. 2 (2023): 152–69. http://dx.doi.org/10.15575/jieb.v2i2.22425.
Texto completo da fontePutri, Berlian Ernita, Nella Yantiana, and Angga Permadi Karpriana. "Penerapan Model Grover dalam Memprediksi Kebangkrutan pada Sektor Farmasi yang Terdaftar di Bursa Efek Indonesia." Manajemen & Bisnis Jurnal 10, no. 2 (2024): 42–54. https://doi.org/10.37303/embeji.v10i2.214.
Texto completo da fonte